ESPERITE (ESP) has concluded new agreements with its note holders
(Thomson Reuters ONE) -
Zutphen, the Netherlands - 31 May 2017
The unfortunate liquidation procedure against Genoma SA, ruled on May 4th 2017,
for which an appeal is still pending, has triggered the obligation to repay
Esperite note holders within 15 business days.
The board has on May 26th 2017 proposed and negotiated the possible issuance of
new notes to repay the note holders.
The note holders, Educe Capital and Frederic Amar, have agreed their notes, for
a total amount of EUR 3'125'000, to be repaid by the issuance of new unsecured
convertible loans.
The new unsecured convertible loan notes will bear interest at a rate of 7% per
year, payable annually in arrears on 31 December and be convertible into
ESPERITE shares according to the initial schedule of the previous notes, until
maturity at an initial conversion price of EUR 0.45.
This initial conversion price is higher than ESPERITE's share price at the time
the offer was presented to the note holders. The conditions of the new
convertible loan notes were discussed and negotiated between the board of
directors and Educe Capital. Mr. Frederic Amar was not part of the decision
making process and the final decision for his notes.
The new notes will mature on 31 December 2019, unless earlier converted or
repurchased, they will not be listed and are subject to shareholders approval.
About ESPERITE
ESPERITE Group (www.esperite.com), listed at Euronext Amsterdam and Paris
(ticker: ESP), established in 2000, is the leading international company in
regenerative and predictive medicine, operational in almost 40 countries with a
network of 6'000 clinics worldwide. ESPERITE serves clients in its state-of-the-
art lab facilities in Switzerland, Belgium, Germany, Dubai, South Africa and
Portugal.
To learn more about the ESPERITE Group, or to book an interview with CEO Mr.
Frédéric Amar: +31 575 548 998 - ir(at)esperite.com or visit the website at
www.esperite.com.
This press release contains inside information as referred to in article 7
paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation)
Esperite has concluded new agreements with its note holders:
http://hugin.info/143308/R/2109272/801425.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Esperite N.V. via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 31.05.2017 - 07:17 Uhr
Sprache: Deutsch
News-ID 545339
Anzahl Zeichen: 2852
contact information:
Town:
Zutphen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 186 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ESPERITE (ESP) has concluded new agreements with its note holders"
steht unter der journalistisch-redaktionellen Verantwortung von
Esperite N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
